Drug Detail:Letermovir (oral/injection) (Letermovir (oral/injection) [ le-term-oh-vir ])
Drug Class: Miscellaneous antivirals
Letermovir Levels and Effects while Breastfeeding
Summary of Use during Lactation
No information is available on the use of letermovir during breastfeeding. Because letermovir is 99% bound to plasma proteins, the amount in milk is likely to be very low. However, an alternate drug may be preferred, especially while nursing a newborn or preterm infant.
Drug Levels
Maternal Levels. Relevant published information was not found as of the revision date.
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
Relevant published information was not found as of the revision date.
Effects on Lactation and Breastmilk
Relevant published information was not found as of the revision date.
Substance Identification
Substance Name
Letermovir
CAS Registry Number
917389-32-3
Drug Class
-
Breast Feeding
-
Lactation
-
Anti-Infective Agents
-
Antiviral Agents
-
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
- Drug Levels and Effects
- Substance Identification